Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
NCT02265627 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2014-10-16
Summary
To investigate the pharmacokinetics of a single dose of BIIL 284 BS in patients with hepatic impairment in comparison to healthy subjects
Conditions
- Hepatic Insufficiency
Interventions
- DRUG
-
BIIL 284 BS
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 24 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-03-31
- Primary Completion
- 2000-09-30
More Related Trials
-
Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS
NCT02265666 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
NCT02624557 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers
NCT02273414 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers
NCT02254538 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment
NCT02254070 ·Status: COMPLETED ·Phase: PHASE1
-
Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
NCT02259868 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems
NCT05661344 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers
NCT02273440 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems
NCT03842761 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers
NCT02273427 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect
NCT02268760 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food
NCT02256787 ·Status: COMPLETED ·Phase: PHASE1
-
BG9928 in Subjects With Hepatic Impairment
NCT00858156 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers
NCT02253940 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers
NCT02259894 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects
NCT02256826 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers
NCT02257021 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects
NCT02183376 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183298 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects
NCT01608087 ·Status: COMPLETED ·Phase: PHASE1
-
Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
NCT02191865 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatic Impairment Study
NCT00829231 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.
NCT02183662 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis
NCT01909778 ·Status: COMPLETED ·Phase: PHASE1